1. Home
  2. IGC vs MOGU Comparison

IGC vs MOGU Comparison

Compare IGC & MOGU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • IGC
  • MOGU
  • Stock Information
  • Founded
  • IGC 2005
  • MOGU 2011
  • Country
  • IGC United States
  • MOGU China
  • Employees
  • IGC N/A
  • MOGU N/A
  • Industry
  • IGC Biotechnology: Pharmaceutical Preparations
  • MOGU Business Services
  • Sector
  • IGC Health Care
  • MOGU Consumer Discretionary
  • Exchange
  • IGC Nasdaq
  • MOGU Nasdaq
  • Market Cap
  • IGC 18.0M
  • MOGU 19.1M
  • IPO Year
  • IGC N/A
  • MOGU 2018
  • Fundamental
  • Price
  • IGC $0.28
  • MOGU N/A
  • Analyst Decision
  • IGC Strong Buy
  • MOGU
  • Analyst Count
  • IGC 2
  • MOGU 0
  • Target Price
  • IGC $3.88
  • MOGU N/A
  • AVG Volume (30 Days)
  • IGC 241.5K
  • MOGU 42.3K
  • Earning Date
  • IGC 02-18-2025
  • MOGU 11-22-2024
  • Dividend Yield
  • IGC N/A
  • MOGU N/A
  • EPS Growth
  • IGC N/A
  • MOGU N/A
  • EPS
  • IGC N/A
  • MOGU N/A
  • Revenue
  • IGC $1,236,000.00
  • MOGU $19,801,126.00
  • Revenue This Year
  • IGC N/A
  • MOGU N/A
  • Revenue Next Year
  • IGC $18.34
  • MOGU N/A
  • P/E Ratio
  • IGC N/A
  • MOGU N/A
  • Revenue Growth
  • IGC 1.65
  • MOGU N/A
  • 52 Week Low
  • IGC $0.25
  • MOGU $1.63
  • 52 Week High
  • IGC $0.66
  • MOGU $3.58
  • Technical
  • Relative Strength Index (RSI)
  • IGC 45.11
  • MOGU 50.53
  • Support Level
  • IGC $0.25
  • MOGU $1.99
  • Resistance Level
  • IGC $0.29
  • MOGU $2.32
  • Average True Range (ATR)
  • IGC 0.02
  • MOGU 0.16
  • MACD
  • IGC 0.00
  • MOGU 0.00
  • Stochastic Oscillator
  • IGC 60.00
  • MOGU 56.16

About IGC IGC Pharma Inc.

IGC Pharma Inc develops advanced cannabinoid-based formulations for treating diseases and conditions, including, but not limited to, Alzheimer's disease, period cramps, premenstrual syndrome and chronic pain. The company has two investigational drug assets targeting Alzheimer's disease, IGC-AD1 and TGR-63, which have demonstrated in Alzheimer's cell lines the potential to be effective in suppressing or ameliorating key hallmarks of Alzheimer's disease, such as plaques or tangles. IGC-AD1 is a low-dose tetrahydrocannabinol-based formulation that is in a 146-person Phase 2 clinical trial for agitation in dementia due to Alzheimer's. IGC also markets a wellness brand, Holief, that targets women experiencing premenstrual syndrome and menstrual cramps.

About MOGU MOGU Inc. (each representing 25)

MOGU Inc is an online fashion and lifestyle destination in China. The company's online platform includes Mogu.com, Mogujie.com, and Meilishuo.com. Its platform allows people to discover and share fashion trends while fully enjoying the shopping experience. The company on its platform provides content related to fashion and lifestyle guides in various multi-media formats which include Live Video Broadcasts, Short-form Videos, Photography, and Online Review Community. The company derives revenues from within China. It also provides online marketing, commission, financing, technology and other relevant services to merchants and users as well as technology services to brands owners.

Share on Social Networks: